West Pharmaceutical Services SG&A Expenses 2010-2024 | WST

West Pharmaceutical Services annual/quarterly sg&a expenses history and growth rate from 2010 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
  • West Pharmaceutical Services sg&a expenses for the quarter ending June 30, 2024 were $0.083B, a 6.11% decline year-over-year.
  • West Pharmaceutical Services sg&a expenses for the twelve months ending June 30, 2024 were $0.349B, a 6.83% increase year-over-year.
  • West Pharmaceutical Services annual sg&a expenses for 2023 were $0.353B, a 11.52% increase from 2022.
  • West Pharmaceutical Services annual sg&a expenses for 2022 were $0.317B, a 12.65% decline from 2021.
  • West Pharmaceutical Services annual sg&a expenses for 2021 were $0.363B, a 20.13% increase from 2020.
West Pharmaceutical Services Annual SG&A Expenses
(Millions of US $)
2023 $353
2022 $317
2021 $363
2020 $302
2019 $273
2018 $263
2017 $246
2016 $240
2015 $233
2014 $229
2013 $235
2012 $218
2011 $191
2010 $188
2009 $178
West Pharmaceutical Services Quarterly SG&A Expenses
(Millions of US $)
2024-06-30 $83
2024-03-31 $87
2023-12-31 $90
2023-09-30 $89
2023-06-30 $88
2023-03-31 $86
2022-12-31 $86
2022-09-30 $66
2022-06-30 $82
2022-03-31 $83
2021-12-31 $98
2021-09-30 $92
2021-06-30 $93
2021-03-31 $80
2020-12-31 $76
2020-09-30 $76
2020-06-30 $78
2020-03-31 $72
2019-12-31 $69
2019-09-30 $65
2019-06-30 $70
2019-03-31 $69
2018-12-31 $60
2018-09-30 $65
2018-06-30 $70
2018-03-31 $68
2017-12-31 $60
2017-09-30 $63
2017-06-30 $61
2017-03-31 $63
2016-12-31 $61
2016-09-30 $58
2016-06-30 $63
2016-03-31 $58
2015-12-31 $62
2015-09-30 $55
2015-06-30 $61
2015-03-31 $55
2014-12-31 $59
2014-09-30 $56
2014-06-30 $58
2014-03-31 $56
2013-12-31 $60
2013-09-30 $56
2013-06-30 $60
2013-03-31 $59
2012-12-31 $59
2012-09-30 $54
2012-06-30 $54
2012-03-31 $51
2011-12-31 $48
2011-09-30 $46
2011-06-30 $46
2011-03-31 $51
2010-12-31 $50
2010-09-30 $45
2010-06-30 $46
2010-03-31 $47
2009-12-31 $45
2009-09-30 $44
2009-06-30 $45
2009-03-31 $43
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $22.428B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $66.939B 18.14
McKesson (MCK) United States $66.345B 18.25
Cardinal Health (CAH) United States $26.957B 14.91
Cooper (COO) United States $22.013B 31.33
Labcorp (LH) United States $19.078B 15.89
Align Technology (ALGN) United States $18.899B 36.51
Henry Schein (HSIC) United States $9.181B 16.81
Merit Medical Systems (MMSI) United States $5.746B 30.37
DENTSPLY SIRONA (XRAY) United States $5.414B 14.52
CONMED (CNMD) United States $2.343B 20.38
Patterson (PDCO) United States $1.936B 10.21
STAAR Surgical (STAA) United States $1.544B 69.76
Lifevantage (LFVN) United States $0.127B 17.48
Pro-Dex (PDEX) United States $0.086B 41.13